Skip to main content
Tobacco Use Insights logoLink to Tobacco Use Insights
. 2024 Aug 19;17:1179173X241271566. doi: 10.1177/1179173X241271566

Activity of the Tobacco Industry in Research and Scientific Literature

Markus Braun 1,, Doris Klingelhöfer 1, Dörthe Brüggmann 1, David A Groneberg 1
PMCID: PMC11334150  PMID: 39166215

Abstract

Introduction

Tobacco companies conduct and fund research. They are not always interested in open-ended research. They promote their interests through public relations campaigns. It’s a proven fact that they influence the scientific community by impairing scientific reputation, especially in the case of health-related research.

Methods

To obtain a comprehensive picture of research and funding activities of the tobacco industry as well as studies about the tobacco industry, respective scientific articles were analyzed in terms of temporal aspects, research areas, networking, and funding sources using established and advanced bibliometric methods.

Results

We found the foci of publications with tobacco industry involvement or funding were mainly in chemistry, toxicology, pharmacology, and agricultural sciences. Health-related scopes occurred much less frequently. In contrast, health and medical sciences were the main focus of publications on the tobacco industry. The Chinese state-owned CNTC was the most research-involved tobacco company and often networked with Chinese academic institutions. Whereas, Western universities, on the other hand, collaborated with tobacco companies to a much lesser extent.

Conclusion

Conflicts of interest of researchers or academic institutions with the tobacco industry occur repeatedly. That is highly problematic and should not be ignored by the scientific community. The science and the public should be skeptical about tobacco industry-supported research.

Keywords: tobacco companies, research output, conflicts of interest, big tobacco, funding, interest-led research support

Introduction

As early as 1939, two surgeons and medical researchers, Alton Ochsner and Michael DeBakey, published their groundbreaking paper on the association between smoking and carcinoma of the lung, 1 confirmed in a landmark article in The Journal of the American Medical Association (JAMA) in 1950. 2 In the 1960s, the Framingham Heart Study found cigarette smoking increases the risk of heart disease. 3 The US Surgeon General’s 1964 report on smoking and health highlighted the health hazards of smoking and was a great media event. 4 In the early 1950s, the tobacco industry started to undermine the scientific findings and evidence of the health risks of smoking by elaborate PR moves intending to impeach the credibility of science. 5 The Chief Executive Officers (CEOs) of the biggest US tobacco companies and the head of a powerful PR company, John W. Hill, established 1954 the “Tobacco Industry Research Committee”, later called the “Council for Tobacco Research” (CTR).5,6 Hill convinced the CEOs that it would be better to support science than to shun it and do science to sow doubt. Their strategy aimed to amplify the skeptics of the link between smoking and diseases, among others, by funding science, creating controversies in the scientific community. 5 They wanted to provide evidence to convince smokers that they have nothing to fear and to reassure the public, particularly smokers. 7 After the dissolution of the two industry-wide research programs, CTR and Center for Indoor Air Research (CIAR), the research grant program “Philip Morris External Research Program” seemed to restore the scientific credibility of the tobacco industry. 8 As late as 1999, tobacco companies maintained the stance that the health hazards of smoking are not proven, although some of their scientists held contrary views not made public. 9 In 2020, at the beginning of the COVID-19 pandemic, news items based on preprints reported worldwide that nicotine protects against COVID-19,10,11 meanwhile disproved. There were connections between the study group of the underlying publications and the tobacco industry. 12 The tobacco industry repeatedly seeks to undermine, influence, and misuse science to its advantage at public health expense.

To what extent and in what ways has the tobacco industry influenced the research landscape, and has anything changed over time? We sought to address this question by conducting bibliometric analyses of the published scientific studies where authors were affiliated with the tobacco industry, studies funded by the tobacco industry, and studies about the tobacco industry. The presented findings of this study enable the interpretation of trends, focal points, and linkages in tobacco industry-related research and their significance for future research projects.

Methods

Methodological platform and data source

This study uses the methods of the established bibliometric platform New Quality and Quantity in Science (NewQIS). 13 NewQIS provides tools for analyses of publication metadata on scientific topics. For this purpose, an internal project algorithm was created, which collects the metadata and stores it in an MS Access database. The database generated in this way is the basis for all further analyses.13,14 The standard data source for scientific literature is Clarivate’s online database Web of Science (WoS), one of the largest online scientific literature databases and well established in bibliometric analyses. WoS lists publications from peer-reviewed and quality journals with their annual citation counts from 1900 to the present.

Search strategy and data processing

Three focal points were formed for the evaluation examining the scientific performance concerning the tobacco industry in more detail: search area A) = SAffiliations: publications of tobacco industry affiliated authors (at least one); search area B) = SFunder: publications funded (at least partly) by the tobacco industry; search area C) = STitle: publications about the tobacco industry.

The following search strategies were used, which combined names of all relevant tobacco companies worldwide and the associated terms that uniquely identify them into a detailed string for each focus.

  • 1. Search area A) = Publications from authors affiliated with the tobacco industry = SAffiliation: WoS Field = AFFILIATION or ADDRESS. Search string: “tobacco industr*” OR “tobacco compan*” OR “tobacco manufact*” OR “tobacco corp*” OR “tobacco factory” OR “tobacco factories” OR “cigar* industr*” OR “cigar* compan*” OR “cigar* manufact*” OR “cigar* producer*” OR “ cigar* factory” OR “ cigar* factories” OR “Philip Morris*” OR “British American Tob*” OR “China Tobacco*” OR “Zhengzhou Tobacco Research Institute*” OR “CNTC” OR “Imperial Brand*” OR “Imperial Tobacco*” OR “Altria*” OR “Japan Tobacco*” OR “Sampoerna tbk” OR “pt Sampoerna” OR “hm Sampoerna” OR “Swedish Match*” OR “Reynolds tobacco” OR ″R.J. Reynolds” OR “RJ Reynolds” OR “Souza Cruz SA*”

  • 2. Search area B) = Publications funded by the tobacco industry = SFunder: WoS Field = FUNDING AGENCY. Search string: Same as for search area A)

  • 3. Search area C) = Publications about the tobacco industry = STitle: WoS Field = TITLE. Search string: “tobacco industr*” OR “tobacco compan*” OR “tobacco manufact*” OR “tobacco corp*” OR “tobacco factory” OR “tobacco factories” OR “cigar* industr*” OR “cigar* compan*” OR “cigar* manufact*” OR “cigar* factory” OR “cigar* factories” OR “Philip Morris” OR “British American Tobacco” OR “Imperial Tobacco” OR “Japan Tobacco” OR “Reynolds tobacco” OR ″R.J. Reynolds” OR “RJ Reynolds” OR “R.J.Reynolds” OR “Altria” NOT “D. Altria”

Each string consists of terms linked with the Boolean operator “OR” using asterisks as placeholders for the sequence of the different characters. After the search input, all entries found were filtered for original articles. No time limit was applied, so all years for each focus were included. However, this resulted in different evaluation periods since the funding agencies were systematically listed in WoS only from August 2008 onwards.

For evaluating the institutions involved, it was necessary to standardize their various designations. The companies Philip Morris International (PMI), Philip Morris Companies Inc, and Altria Group have been combined under the term Philip Morris, based in the USA (Corporate Headquarters) and Switzerland (Operations Center), for reasons of company history. The countries of origin of the founded articles have been updated with a current list of countries and regional territories.

The collected and manually standardized data was stored in an MS Access database and sorted for the three search processes (SAffiliation, SFunder, STitle) according to the parameters to be analyzed.

Data analysis

The analyses were carried out separately for the retrieved metadata of the publications of the three search strategies (SAffiliation, SFunder, STitle) based on the generated databases.

The data were analyzed according to chronological parameters, including annual publications, citation counts, and citation rates. The citation rates were calculated by the quotient of citations per article. Furthermore, the number of articles was related, also by calculation of the quotient, to the number of Science Citation Index Expanded (SCIE) articles to show the relative development of publication numbers. Also, the most cited articles were identified. Another focus was the analysis of the respective research areas. For this purpose, the WoS research categories were analyzed, whereby the most frequently assigned categories were identified, and their proportional change was determined at 5-year intervals.

The publishing institutions of the three search areas were analyzed, which required the standardization and normalization of all assigned affiliations. The so-identified most-publishing tobacco companies were also analyzed regarding the number of articles, citations, and citation rates. Cooperation networks at the institutional and national levels were analyzed. A cooperation article is defined as having at least two affiliations from different countries (national level) or authors from different institutional affiliations (institutional level). Matrices with values of cooperation were computed and transformed into vectors by a developed software module. 14

The funding of research was another focus of this study. The funding organizations were identified for all three search areas. For this purpose, the sources of financing had to be standardized, the designation of the funds and the separately listed financing numbers assigned to a source organization or a company.

In addition, the publishing journals were analyzed and compared for the three search areas (SAffiliation, SFunder, STitle).

Results

In the WoS database, beginning January 1900 until January 2022, n = 8077 articles were found where at least one tobacco industry affiliated author (SAffiliation). These articles were cited 138 058 times in this period, meaning a citation rate cr = 17.09. The WoS category “Funding Agency” is available just since August 2008. 15 From 2008 until January 2022, n = 3186 articles were found funded by the tobacco industry (SFunder), which were cited 55 545 times in that period (cr = 17.43). From January 1900 until January 2022, n = 2204 articles about the tobacco industry (STitle) were found, cited 23 321 times (cr = 10.58). Figure 1 shows the publication development over time of all three search areas.

Figure 1.

Figure 1.

Publication development over time with the number of articles, number of citations, and citation rate. Only completed years are included. A: Articles from authors affiliated with the tobacco industry from 1900 to 2021. B: Articles funded by the tobacco industry from 2009 to 2021. C: Articles about the tobacco industry from 1900 to 2021. D: Relative number of articles (search areas SAffiliation, SFunder, STitle) per 10 000 articles listed in the Science Citation Index Expanded (SCIE) database of Web of Science. TI = Tobacco industry.

Publication development over time

SAffiliation

The first article we found by authors affiliated with the tobacco industry, titled ‘Chemistry as an Aid to the Tobacco Industry’, was published in 1922. 16 The sole author was a chemist of The American Tobacco Company (British American Tobacco, BAT). By 1966, we identified only four more articles published by authors affiliated with the tobacco industry. Between 1968 and 1972, n = 18 articles overall were identified. 1973 was the first year with a two-digit publication number (n = 26). From then on, the number of publications per year increased more or less consistently until 2009 (n = 158 articles). From 2010 to 2021, the slope increased and reached n = 575 in 2021, the peak so far. The annual citations (c) increased abruptly from c = 9 in 1972 to c = 344 in 1973 and continued to rise subsequently to c = 5224 in 2016, with peaks in 1994 (c = 4605), 1996 (c = 5110), 2006 (c = 9031), and decreased afterward to 552 in 2021. The 23 articles published between 1900 and 1972 were cited very sparsely, except for the second and third publication from 1936 and 1937, with c = 81 and c = 28, respectively. The publications from 1966, 1968, and 1972 reached, by contrast, only cr = 4, 0.5, and 1.8, respectively. From 1973 onwards, the citation rate increased from 13.23 to 51.9 in 2006, with peaks in 1977 (cr = 20.71), 1994 (cr = 48.47), and 1996 (cr = 40.88), and decreased then to 1.04 in 2021 (Figure 1(A)).

The annual ratio of articles from authors affiliated with the tobacco industry and all SCIE articles jumped between 1972 and 1976 from far below 1 to 1.32 articles per 10 000 SCIE articles and again in 2013 to 1.75 and further increased to 2.2 in 2021 (Figure 1(D)).

SFunder

From 2009 to 2021, the number of articles funded by the tobacco industry increased relatively consistently from n = 166 to n = 413 per year, with a slightly steeper rise since 2018. The number of citations decreased steadily from c = 7694 in 2009 to c = 374 in 2021. The citation rate decreased likewise from cr = 46.35 in 2009 to cr = 0.97 in 2021 (Figure 1(B)).

The annual ratio of tobacco industry-funded and listed SCIE articles increased from 1.11 in 2009 to 1.58 in 2021 per 10.000 (Figure 1(D)).

STitle

The first article identified about the tobacco industry was published in 1900 in JAMA and dealt with tobacco amblyopia - a visual impairment due to tobacco - among tobacco factory employees in Cincinnati, USA. 17 Through 1968, n = 32 more articles were published, with a maximum of three articles per year (1965 and 1967). 1969 was the first year with two-digit publication number (n = 11), followed by 1974 with n = 10, and 1981 with n = 23 publications per year. From then on, the number of articles per year remained consistent between n = 9 and n = 28 until 1994. From 1995 until 2021, the number increased slowly from n = 44 to n = 72, with little peaks in 2006 (n = 81), 2018 (n = 137), 2019 (n = 97), and 2020 (n = 94). The 33 articles published between 1900 and 1968 were only ten times cited overall. 1969 was the first year with a two-digit number of citations (n = 20), followed by 1972 (n = 11) and 1973 (n = 12). 1981 showed the first peak with n = 133 citations, also 1985 (n = 138) and 1991 (n = 127). From 1993, the number of citations rose from 114 to the highest, 2237 in 2002, followed by four-digit numbers between c = 1208 and c = 1700 from 2003 to 2006 and 2008. Afterward, the number of citations decreased to 42 in 2021. The citation rate followed approximately the run of the citation curve, with the highest peak also in 2002 (cr = 33.39) (Figure 1(C)).

The annual ratio of articles about the tobacco industry per 10.000 SCIE articles fluctuated between 0 and 0.75 (Figure 1(D)).

Table S1 in the supplementary files lists the ten most cited articles in the three analyzed search areas.

Research areas

Figure 2 shows the evolution of the ten most assigned WoS research areas in 5-year intervals from 1973 to 2022 (SAffiliation and STitle), respectively 2008 to 2022 (SFunder). Table 1 lists the 15 most assigned WoS research areas of the three search areas sorted by the number of articles. Additionally, Table S2 in the supplementary files lists all assigned WoS research areas with at least one article sorted by the number of articles.

Figure 2.

Figure 2.

Relative share of the ten most assigned Web of Science (WoS) research areas in 5-year intervals sorted by affinity. A: Articles from authors affiliated with the tobacco industry from 1973 to 2022. B: Articles funded by the tobacco industry from 2008 to 2022. C: Articles about the tobacco industry from 1973 to 2022.

Table 1.

Fifteen most assigned Web of Science (WoS) research areas sorted by number of articles of the three search areas (SAffiliation, SFunder, STitle) analyzed with stated percentage of the total number of articles.

WoS Research Area Articles Percentage Citations Citation Rate
A: SAffiliation
 Chemistry 2241 18.7 35258 15.73
 Toxicology 1128 9.4 19520 17.30
 Biochemistry & Molecular Biology 959 8 22161 23.11
 Pharmacology & Pharmacy 872 7.3 12953 14.85
 Engineering 599 5 9206 15.37
 Plant Sciences 465 3.9 10892 23.42
 Food Science & Technology 437 3.7 8616 19.72
 Agriculture 432 3.6 5015 11.61
 Materials Science 392 3.3 9051 23.09
 Genetics & Heredity 251 2.1 4793 19.10
 Environmental Sciences & Ecology 241 2 3502 14.53
 Biotechnology & Applied Microbiology 235 2 4432 18.86
 Physics 198 1.7 5317 26.85
 Science & Technology - Other Topics 198 1.7 3937 19.88
 Energy & Fuels 160 1.3 5538 34.61
B: SFunder
 Chemistry 569 12.4 7001 12.30
 Pharmacology & Pharmacy 330 7.2 5776 17.50
 Toxicology 319 6.9 5244 16.44
 Plant Sciences 274 6 2719 9.92
 Biochemistry & Molecular Biology 246 5.3 6759 27.48
 Agriculture 204 4.4 1237 6.06
 Engineering 187 4.1 2295 12.27
 Environmental Sciences & Ecology 172 3.7 2194 12.76
 Science & Technology - Other Topics 143 3.1 4080 28.53
 Microbiology 131 2.8 1243 9.49
 Biotechnology & Applied Microbiology 125 2.7 2407 19.26
 Materials Science 122 2.6 2772 22.72
 Food Science & Technology 114 2.5 1327 11.64
 Neurosciences & Neurology 114 2.5 2727 23.92
 Genetics & Heredity 103 2.2 2038 19.79
C: STitle
 Public, Environmental & Occupational Health 845 26.7 15079 17.84
 Substance Abuse 563 17.8 9904 17.59
 General & Internal Medicine 451 14.3 4188 9.29
 Business & Economics 185 5.9 1172 6.34
 Government & Law 85 2.7 339 3.99
 History 75 2.4 51 0.68
 Engineering 67 2.1 147 2.19
 Health Care Sciences & Services 61 1.9 626 10.26
 Social Sciences - Other Topics 53 1.7 293 5.53
 Oncology 51 1.6 286 5.61
 Respiratory System 44 1.4 73 1.66
 Psychiatry 41 1.3 713 17.39
 Science & Technology - Other Topics 33 1 156 4.73
 Computer Science 32 1 31 0.97
 Agriculture 30 0.9 218 7.27

SAffiliation

The 8077 articles were 11 962 times listed in 120 WoS research areas. Among the ten most assigned research areas (Figure 2(A)), the focus areas were chemical and life sciences and technology and engineering, respectively, taking into account that Chemistry took the highest proportion over the years either more or less consistently. From 1973 onwards, the relative share of the WoS research areas Biochemistry & Molecular Biology and Agriculture decreased rather distinctly, and that of Toxicology, Pharmacology & Pharmacy, Material Science, and Engineering increased more or less. The research areas Public, Environmental & Occupational Health (rank 21 of 120) and Oncology (rank 25) were the most assigned in the fields of health and medical sciences, with a relative share of barely 1% each (Supplement Table. S2A).

SFunder

The 3186 articles funded by the tobacco industry were 4605 times listed in 111 WoS research areas. The ranking of the ten most assigned WoS research areas was similar to that of search area SAffiliation. It differed that in place of Genetics & Heredity, Food Science & Technology, and Materials Science, the WoS research areas Microbiology, Environmental Sciences & Ecology, and Science & Technology – Other Topics were among the first ten (Figure 2(B)). Here also Chemistry had the highest share of all listed research areas, and, likewise, research areas from the health or medical sciences played a more of a minor part. Public, Environmental & Occupational Health was the first listed in this area with a share of under 2% (rank 16 of 111) (Supplement Table. S2B).

STitle

The 2204 articles about the tobacco industry were 3162 times listed in 96 WoS research areas. Among the ten most assigned WoS research areas, compared to the search areas SAffiliation and SFunder, only Engineering was also listed here (Figure 2(C)). Four research areas belonged to health or medical sciences, Public, Environmental & Occupational Health (rank 1), General & Internal Medicine (rank 3), Health Care Sciences (rank 8), and Oncology (rank 10) representing 44.5% of all listed articles (Tab. S2C).

Most publishing tobacco companies

Table 2 shows the most publishing tobacco companies and institutions concerning the three search areas sorted by the number of articles. In the table, the thresholds for institutions were set at 50 articles for search areas SAffiliation and SFunder and at 20 articles for STitle. All tobacco companies with at least one article were listed.

Table 2.

Most publishing tobacco companies and institutions in the three search areas (SAffiliation, SFunder, STitle) measured by the number of articles. CNTC = China National Tobacco Corporation. JTI = Japan Tobacco Inc. PM = Philip Morris. RJR = R. J. Reynolds Tobacco Company. BAT = British American Tobacco.

Tobacco Company / Institution Country Articles Citations Citation Rate
A: SAffiliation: List threshold at least 50 articles plus tobacco companies with at least one article
 CNTC China 2540 21755 8.56
 JTI Japan 1884 42559 22.59
 PM International 1832 41343 22.57
 RJR USA 696 13158 18.91
 BAT UK 565 8897 15.75
 Chinese Academy of Science China 253 5575 22.04
 University of Tokyo Japan 164 5591 34.09
 Yunnan University China 113 780 6.90
 University of Science and Technology of China China 108 1289 11.94
 Zhejiang University China 97 1363 14.05
 Chinese Academy of Agricultural Sciences China 93 578 6.22
 Henan Agricultural University China 90 501 5.57
 Kyoto University Japan 79 2227 28.19
 Yunnan Minzu University China 79 375 4.75
 Zhengzhou University of Light Industry China 77 350 4.55
 Imperial Brands UK 76 691 9.09
 Kunming University of Science and Technology China 69 384 5.57
 Virginia Commonwealth University USA 64 1712 26.75
 Zhengzhou University China 64 545 8.52
 Sun Yat-sen University China 59 364 6.17
 Henan University of Technology China 52 703 13.52
 Sichuan University China 51 396 7.76
 Tobacco Manufacturers Association (TMA) UK 6 4 0.67
B: SFunder: List threshold at least 50 articles plus tobacco companies with at least one article
 CNTC China 1179 8573 7.27
 PM International 279 4001 14.34
 BAT UK 131 2250 17.18
 Chinese Academy of Agricultural Sciences China 130 900 6.92
 Yunnan University China 128 1513 11.82
 Chinese Academy of Science China 124 2081 16.78
 Henan Agricultural University China 116 858 7.40
 Southwest University China 106 1325 12.50
 Guizhou University China 76 367 4.83
 JTI Japan 75 1308 17.44
 University of Science and Technology of China China 68 889 13.07
 Virginia Commonwealth University USA 66 1567 23.74
 North Carolina State University USA 64 824 12.88
 Zhejiang University China 60 680 11.33
 Hunan Agricultural University China 52 287 5.52
 RJR USA 26 419 16.12
 Imperial Brands UK 14 148 10.57
 Swedish Match Sweden 9 120 13.33
 Souza Cruz Brazil 1 48 48
C: STitle: List threshold at least 20 articles plus tobacco companies with at least one article
 University of California. San Francisco USA 238 7795 32.75
 University of London UK 93 1800 19.35
 University of Bath UK 61 1557 25.52
 University of Sydney Australia 50 992 19.84
 Harvard University USA 36 1244 34.56
 CNTC China 29 70 2.41
 Johns Hopkins University USA 26 393 15.12
 University of Edinburgh UK 26 706 27.15
 University of York UK 24 233 9.71
 Mayo Clinic USA 24 770 32.08
 Simon Fraser University Canada 22 160 7.27
 PM International 16 12 0.75
 BAT UK 8 33 4.13
 RJR USA 2 13 6.50
 JTI Japan 1 0 0

SAffiliation

Among the 8077 articles, the government-owned China National Tobacco Corporation (CNTC, China) led the ranking with a contribution to 2540 articles (31.45%). Japan Tobacco Inc (JTI, Japan) follows with n = 1884 (23.33%), Philip Morris (PM, USA and Switzerland) with n = 1832 (22.68%), R. J. Reynolds Tobacco Company (RJR, USA) with 694 (8.59%), and British American Tobacco (BAT, UK) with n = 565 (7%).

SFunder

Among the 3186 tobacco industry-funded articles, CNTC sponsored 1179 articles (37%), followed by PM with 279 (8.76%), BAT with 131 (4.11%), JTI with 75 (2.35%), RJR with 26 (0.82%), and Imperial Brands (IB, UK) with 14 articles (0.44%).

STitle

Among the 2204 articles about the tobacco industry, only a few were with a contribution by tobacco companies: CNTC (n = 29), PM (n = 16), BAT (n = 8), RJR (n = 2), and JTI (n = 1). Here dominated universities from the USA, UK, and Australia.

Collaborations of the leading tobacco companies and institutions

Figure 3 illustrates the collaboration networks of the respective tobacco companies and institutions in the three search areas.

Figure 3.

Figure 3.

Collaboration networks of the tobacco companies and institutions. Numbers: number of common articles/number of citations. A: Publications from authors affiliated with the tobacco industry. Threshold for display: 30 collaboration articles. B: Publications funded by the tobacco industry. Threshold for display: 10 collaboration articles. C: Publications about the tobacco industry. Threshold for display: 3 collaboration articles.

SAffiliation

CNTC collaborated predominantly with 18 Chinese universities, the Chinese Academy of Sciences (CAS), and the Chinese Academy of Agricultural Sciences (CAAS). The Japanese tobacco company JTI collaborated mainly with four Japanese universities. Most frequently, RJR collaborated with one US and one Romanian university, and PM with one US and one Dutch university (Figure 3(A)).

SFunder

CNTC collaborated mainly with 29 Chinese universities and three academies, CAS, CAAS, and the Yunnan Academy of Agricultural Sciences. A few networks among themselves between Chinese universities are visible. Additionally, four small networks collaborated on at least ten articles, namely JTI with the University of Tokyo, RJR with BAT, PM with two Dutch universities, and two US universities (Figure 3(B)).

STitle

The institutional collaboration networks concerning articles about the tobacco industry (display threshold of at least three collaboration articles) showed no participation of any tobacco company (Figure 3(C)). Two collaborations were found between BAT and PM, the only collaborations of tobacco companies among themselves. Most collaborating institutions were universities from the USA and the UK, besides a Swiss association against smoking (OxyRomandie), 18 an independent non-profit research institute (RTI International, USA), 19 a non-profit cancer charity organization (Cancer Council Victoria, Australia), 20 an independent organization against drugs (Alcohol & Drug Information Centre, Sri Lanka), 21 a network of 13 universities focused on spreading information on Tobacco and alcohol (UK Centre for Tobacco and Alcohol Studies), 22 and the American Cancer Society. 23

Most publishing countries and international collaborations

Table 3 lists the most publishing countries, and Table 4 international collaborations in the three search areas. Supplement Figure S1 in the supplementary files shows the collaborations on articles at the country level.

Table 3.

Most publishing countries (threshold 30 articles at search areas SAffiliation and SFunder, 10 articles at search area STitle sorted by the total number of articles with the declaration of the share of collaboration articles.

Country Articles Collaboration Articles Collaboration Articles (%)
A: SAffiliation
 China 2628 257 9.8
 USA 2403 641 26.7
 Japan 2064 199 9.6
 Switzerland 718 448 62.4
 UK 671 320 47.7
 Germany 334 318 95.2
 France 90 66 73.3
 Canada 88 63 71.6
 Singapore 84 83 98.8
 Italy 84 39 81.3
 Netherlands 83 81 97.6
 Belgium 70 68 97.1
 Sweden 66 39 59.1
 Romania 46 46 100
 Australia 37 36 97.3
 Spain 35 35 100
 Austria 35 33 94.3
 Brazil 32 17 53.1
B: SFunder
 China 1662 225 13.5
 USA 945 376 39.8
 Switzerland 266 179 67.3
 UK 258 158 61.2
 Germany 163 129 79.1
 Japan 159 41 25.8
 Canada 70 56 80
 Italy 58 36 62.1
 Netherlands 49 49 100
 France 36 30 83.3
 Sweden 35 22 62.9
 Denmark 33 18 54.5
 Spain 32 31 96.9
C: STitle
 USA 825 115 13.9
 UK 276 82 29.7
 Australia 123 33 26.8
 China 107 19 17.8
 Canada 97 45 46.4
 India 38 9 23.7
 Germany 31 11 35.5
 Brazil 27 11 40.7
 Switzerland 26 12 46.2
 New Zealand 26 7 26.9
 Spain 22 7 31.8
 Japan 19 5 26.3
 Netherlands 14 6 42.9
 Thailand 13 8 61.5
 Finland 13 5 38.5
 Mexico 13 5 38.5
 Belgium 10 8 80

Table 4.

Bilateral collaborations at country level sorted by the number of collaboration articles in the three search areas SAffiliation (threshold 20 articles), SFunder (threshold 15 articles), and STitle (threshold 5 articles).

Collaboration Countries Collaboration Articles Collaboration Countries Collaboration Articles
A: SAffiliation
 USA/Switzerland 157 Switzerland/Italy 24
 Switzerland/Germany 152 UK/France 23
 USA/Germany 132 Singapore/Germany 22
 USA/UK 131 USA/Italy 22
 USA/China 111 USA/Sweden 22
 USA/Japan 111 UK/Austria 21
 UK/Germany 87 Switzerland/France 21
 UK/Switzerland 69 USA/France 21
 Switzerland/Singapore 64 USA/Belgium 20
 Switzerland/Netherlands 57 UK/Canada 20
 Germany/Belgium 43 UK/China 20
 USA/Romania 42 UK/Italy 20
 Switzerland/Japan 40 UK/Japan 20
 USA/Canada 37 USA/Netherlands 20
 Switzerland/Belgium 24 UK/Sweden 20
B: SFunder
 USA/China 115 USA/Japan 22
 USA/UK 72 UK/Switzerland 20
 Switzerland/Germany 64 UK/Canada 19
 USA/Germany 60 USA/Italy 19
 USA/Switzerland 58 Switzerland/Singapore 19
 USA/Canada 31 USA/Spain 17
 Switzerland/Netherlands 30 UK/Italy 16
 UK/Germany 24 UK/China 15
 Pakistan/China 22 USA/Netherlands 15
C: STitle
 USA/UK 22 USA/Brazil 7
 USA/Canada 21 UK/Lebanon 6
 UK/Canada 18 UK/Switzerland 6
 USA/Australia 13 USA/Argentina 5
 UK/Australia 9 USA/Germany 5
 USA/China 8

SAffiliation

The six most publishing countries were China, the USA, Japan, and, followed by a considerable gap, Switzerland, the UK, and Germany (Table 3A). These countries were collaborating first of all among themselves, especially the USA with Switzerland, Germany, the UK, China, or Japan, and Switzerland with Germany, to name the leading six bilateral collaborations (Table 4A, Supplement Figure S1(A)).

SFunder

The six most publishing countries were China and the USA, followed by a bigger gap by Switzerland, the UK, Germany, and Japan (rank six in place of three) (Table 3B). The most bilateral networking occurred again between the USA and China, the UK, Germany, Switzerland, and Canada. Another identified network among the first six was between Switzerland and Germany on rank three (Table 4B, Supplement Figure S1(B)).

STitle

The most publishing country was the USA, followed by a bigger gap by the UK, Australia, China, Canada, and India, to name the leading six (Table 3C). Germany followed on rank seven, Switzerland nine, and Japan on rank 12. Most collaborations occurred between the USA and the UK, Canada, Australia, and China, and, additionally, between the UK and Canada and Australia, respectively (Table 4C, Figure S1(C)).

Research funding

SAffiliation

Of the overall 8077 articles, 2895 articles (35.84%) were funded and received in sum 6378 grants (g), of them g = 1596 (25.02%) from the tobacco industry, including g = 981 (61.47%) from CNTC, g = 324 (20.3%) from PM, g = 138 (8.65%) from BAT, g = 73 from JTI (4.57%), g = 28 (1.75%) from RJR, and g = 27 (1.69%) from IB, to name the six most funding tobacco companies.

SFunder

Among the 3186 tobacco industry-funded articles, from 9136 grants, g = 3380 (37%) could be assigned to the tobacco industry. Of these, g = 1938 (57.34%) were awarded by CNTC, followed by PM with g = 914 (27.04%), BAT with g = 178 (5.27%), JTI with g = 134 (3.96%), RJR with g = 96 (2.84%), IB with g = 46 (1.36%), and Swedish Match with g = 25 (0.74%), to name the companies with at least two digits quantity of grants they awarded.

STitle

In 2204 articles, only 12 tobacco industry assignable grants from overall g = 1293 were found, meaning less than 1%, eight from CNTC, and each one from PM, BAT, Tabacalera SLU (Cuba), and Tabacuba (Cuba).

Most publishing journals

Table 5 lists the 15 most publishing journals sorted by the number of articles in the three analyzed search areas, including information about the respective journal category (subject area) and the Journal Impact Factors (JIFs) from the database of the Journal Citation Reports™ from Clarivate (accessed on 23 February 2023).

Table 5.

The 15 most publishing journals sorted by the number of articles of the three search areas (SAffiliation, SFunder, STitle) analyzed. In brackets are the ournal Impact Factors From Clarivates’ Journal Citation Reports™ (accessed on 23 February 2023). n/a = not available (not indexed in Journal Citation Reports database).

Journal (Impact Factor) Journal Category (Subject Area) Articles Citations Citation Rate
A: SAffiliation
 Agricultural and Biological Chemistry (n/a) Bioscience, Biotechnology, Agrochemistry 252 3311 13.14
 Abstracts of Papers of the American Chemical Society (n/a) Chemistry 179 3 0.02
 Regulatory Toxicology and Pharmacology (3.598) Toxicology, Pharmacology, Legal Medicine 168 3532 21.02
 Toxicology Letters (4.271) Toxicology 154 394 2.56
 Journal of Chromatography A (4.601) Chemistry, Biochemical Research Methods 89 1937 21.76
 Inhalation Txicology (3.011) Toxicology 89 1509 16.96
 Food and Chemical Toxicology (5.572) Toxicology, Food Science & Technology 88 3489 39.65
 Journal of Agricultural and Food Chemistry (5.895) Chemistry, Agriculture, Food Science & Technology 76 1795 23.62
 Heterocycles (0.689) Chemistry 66 702 10.64
 Journal of Analytical and Applied Pyrolysis (6.437) Chemistry, Energy & Fuels, Chemical Engineering 65 2596 39.94
 Phytochemistry (4.004) Biochemistry & Molecular Biology, Plant Sciences 64 1341 20.95
 Contributions to Tobacco Research International (n/a) Agricultural and Biological Sciences 62 552 8.90
 Mutation Research (2.107) Toxicology, Genetics & Heredity 62 1291 20.82
 Journal of Chromatographic Science (1.555) Chemistry, Biochemical Research Methods 58 1001 17.26
 Scientific Reports (4.997) Multidisciplinary Sciences 55 565 10.27
B: SFunder
 Regulatory Toxicology and Pharmacology (3.598) Toxicology, Pharmacology, Legal Medicine 81 1227 15.15
 Scientific Reports (4.997) Multidisciplinary Sciences 50 625 12.50
 Nicotine & Tobacco Research (5.825) Public, Environmental & Occupational Health, Substance Abuse 40 844 21.10
 Chemistry of Natural Compounds (0.830) Chemistry 33 95 2.88
 International Journal of Systematic and Evolutionary Microbiology (2.689) Microbiology 27 188 0.14
 Asian Journal of Chemistry (0.355) Chemistry 25 61 0.41
  Journal of Separation Science (3.614) Chemistry 25 194 0.13
 Toxicology Letters (4.271) Toxicology 23 141 0.16
 Toxicology In Vitro (3.685) Toxicology 23 501 0.05
 Inhalation Toxicology (3.011) Toxicology 23 478 0.05
 Plant Disease (4.614) Plant Sciences 22 78 0.28
 Heterocycles (0.689) Chemistry 22 181 0.12
 Food and Chemical Toxicology (5.572) Toxicology, Food Science & Technology 20 443 0.05
 Journal of Agricultural and Food Chemistry (5.895) Chemistry, Agriculture, Food Science & Technology 20 316 0.06
 Journal of Aerosol Science (4.586) Engineering, Meteorology & Atmospheric Sciences, Environmental Sciences 20 366 0.05
C: STitle
 Tobacco Control (6.953) Public, Environmental & Occupational Health, Substance Abuse 406 8581 21.14
 The BMJ (96.216) General & Internal Medicine 176 629 3.57
 Lancet (202.731) General & Internal Medicine 104 853 8.20
 American Journal of Public Health (11.576) Public, Environmental & Occupational Health 72 2715 37.71
 Tobacco Induced Diseases (5.163) Public, Environmental & Occupational Health, Substance Abuse 68 7 0.10
 JAMA-Journal of the American Medical Association (157.375) General & Internal Medicine 35 1104 31.54
 Nicotine & Tobacco Research (5.825) Public, Environmental & Occupational Health, Substance Abuse 34 603 17.74
 Addiction (7.256) Psychiatry, Substance Abuse 29 591 0.05
 PLOS Medicine (11.613) General & Internal Medicine 17 698 41.06
 European Journal of Public Health (4.424) Public, Environmental & Occupational Health 17 175 0.10
 Canadian Medical Association Journal (16.876) General & Internal Medicine 16 20 0.80
 Global Public Health (3.356) Public, Environmental & Occupational Health 16 157 0.10
 American Journal of Agricultural Economics (3.757) Economics 14 99 0.14
 Fortune (0.285) Business 12 2 0.17
 Medical Journal of Australia (12.776) General & Internal Medicine 12 12 1

SAffiliation

Of the 15 most publishing journals, the first 14 were widely in the fields of biosciences, chemistry, toxicology, engineering, and plant or agricultural sciences. A multidisciplinary journal ranked 15. Disciplines of medicine were not listed, except legal medicine in one case. The JIFs were all below seven, and the top two journals were not indexed in the Journal Citation Reports™ database. Of note, the 12th-ranked German Journal, Contributions to Tobacco Research International (original German title: Beiträge zur Tabakforschung, currently: Contributions to Tobacco & Nicotine Research) was originally published by the German Association of Cigarette Industries (German: VdC, Verband der Cigarettenindustrie). 24

SFunder

Again, most of the journals listed were in the categories of chemistry, toxicology, engineering respective technology, and plant or agricultural sciences. In second place was a multidisciplinary journal, and in third was a journal in the fields of public, environmental and occupational health and substance abuse, respectively. The JIFs were all below six.

STitle

A different picture emerged here. All of the journals listed belonged to the medical categories, except one in economics (rank 13) and one in business (rank 14). Moreover, three markedly high-impact journals were found with JIFs of approximately 100 and above. Another four journals had JIFs above 10.

Discussion

The tobacco industry is increasingly involved in research. Thus, policymakers, consumers, academics, and, not least, publishers should all remain cautious, given the industry’s documented history of attempting to influence science for its gain at the expense of public health.

Therefore, we analyzed the publication behavior and topics of the tobacco industry in scientific publications using the WoS database. We sectioned this bibliometric study into three investigation areas: (1) the investigation of publications of authors affiliated with the tobacco industry, (2) publications funded by them, and (3) publications about the tobacco industry to identify differences compared to investigation areas (1) and 2).

First, we looked at the total number of articles, their citation numbers, the resulting citation rates of each search area, and their development over time. The first identified article about the tobacco industry was published in 1900 in JAMA. 17 We found only 32 articles until 1968 inclusive. This trend is similar to the development of publications of tobacco industry-affiliated authors (n = 9). Until this time, it would seem that the interest in scientific publications on the part of both the tobacco industry and the scientific community in studies about the tobacco industry was limited. We found no publications in the WoS database as a direct response to findings published in 1939, 1950, or the 1960s concerning health effects like lung cancer or heart disease13 by authors affiliated with the tobacco industry, nor to the 1964 report of health hazards by smoking by the US Surgeon General. 25 Our study confirms insofar that the tobacco industry’s strategies were more likely the reputational damage of science through PR campaigns. 5 The 1972 report of the US Surgeon General was the first report on the health consequences of smoking, which included the health hazards of passive smoking. 26 The tobacco industry answered with scientific, public, and political disinformation campaigns and sponsored research to trivialize the health hazard of passive smoking. 27 Since 1972, the relative share of publications in which tobacco industry-affiliated authors were involved increased rapidly, indicating an increase in research interest on the side of the tobacco industry. The first studies we found by tobacco industry-affiliated authors that addressed the chemical or biological effects of tobacco ingredients or cigarette smoke condensate were published in 1973 without explicit mention of the health hazards of smoking.28-31 According to the WoS research areas, studies associated with or funded by the tobacco industry were largely unrelated to health issues. Not surprisingly, there were few studies whose authors were affiliated with or were funded by the tobacco industry and that addressed the health effects of smoking. By contrast, many articles about the tobacco industry were published in journals dealing with health topics. That was also underlined by the subject areas of the most-publishing journals. Articles by tobacco industry-affiliated authors and tobacco industry-funded articles were mainly published in journals dealing with chemistry, toxicology, or agriculture, and articles about the tobacco industry, by contrast, mainly in journals with health-related topics. Nevertheless, the funding of medical research by tobacco companies is ubiquitous, even if it is only that, eg, health-related foundations receive money from them. 32

As other studies have already shown, institutional scientific collaborations have generally fanned out into broad networks.33,34 That is also true for articles about the tobacco industry. The situation is quite different for studies in which the tobacco industry was involved, either with affiliated authors or through funding. The networks of the Chinese governmental tobacco company CNTC with many Chinese academic institutions are remarkable. Besides its research capacity, CNTC benefits from Chinese universities to further its research agenda, primarily in agriculture, production, and business management, but, increasingly, also in the so-called ‘less harmful, low-tar’ strategy. 35 Networks of Western universities with tobacco companies could only be detected on a much lower level, as they presumably are wary of relationships with the tobacco industry due to their reputation. 35 In line with these findings, for China, besides Japan, collaborations at the country level are below average. That also indicates that research involving tobacco companies (here: CNTC and JTI, respectively) is more likely to be interest-driven. Possibly, international collaborations would be more of a hindrance than a help here, also because the tobacco industry may have greater control over narratives and communities within their “hometown”.

CNTC is the largest tobacco company in the world. 36 We have found that CNTC is also the most research-supporting tobacco company by far, both by CNTC-affiliated authors and funding. The other ‘Big Tobacco’, Philip Morris, British American Tobacco, Japan Tobacco, Imperial Brands, but even RJ Reynolds, follow at some distance in research support, at least as far as non-disguised funding is concerned. By its very nature, the tobacco industry is virtually uninvolved in studies about themselves. However, they have a long history of establishing third-party organizations to fund research and scientists. That leads naturally to conflicts of interest. 37 It has become known that the tobacco industry uses scientists and research projects for its purposes and continues to systematically stir up controversies about the health hazards of smoking and scientific evidence. 38 Notably, about one-third of publications with tobacco industry-affiliated authors received grants from the tobacco industry. Not surprisingly, articles about the tobacco industry were almost not funded by the industry.

Studies on internal tobacco industry documents revealed post hoc protocol changes and biased experimental set-ups in scientific publications linked to tobacco companies.39,40 Tobacco industry research did not meet standards for clinical research. 41 Publishing tobacco industry-affiliated or funded research in scientific journals is controversially discussed. 42 Several journals and academic institutions decided to stop publishing tobacco industry-supported research.43,44 Unfortunately, even leading medical journals have no tobacco policies that prohibit studies funded by the tobacco industry. 45 The question arises whether rather medical journals fear to publish studies with results favorable to the tobacco industry or are non-medical journals regarding tobacco policies by far less restrictive. Future studies should analyze the publication policies of scientific journals and publishers. On the other hand, the tobacco industry publishes in non-peer-reviewed journals that suggest meeting scientific standards. Funding and disseminating non-peer-reviewed research is a longstanding strategy. 44 That could also be true for medical journals and research, leading to lower entries in the WoS database as WoS does not list non-peer-reviewed journals. Journals in the fields where the tobacco industry provides extraordinary support (eg, chemistry, toxicology, pharmacology, or agriculture) would do well to be skeptical, not least because the tobacco industry is interested in normalization of their presence within science and academia, even if it’s not dealing with tobacco. 37 The presented findings of this study enable the interpretation of trends, focal points, and linkages in tobacco industry-related research and their significance for future research projects.

All bibliometric studies have limitations depending on the used database and search strategies. The applied core collection of WoS has strict indexing requirements for journals. For example, it only contains journals that practice a standard peer-review process, so articles published in non-indexed journals are not included in the analysis. Journals that do not meet the requirements of WoS are not listed. The English bias of WoS favors English literature, so not all related publications in other languages could be included in the analysis database. WoS cannot filter out incorrect or self-citations. That can distort figures or ratios for all citation parameters. Publications before 1900 were not included as this is the lower limit of the evaluation period of WoS. In addition, WoS began just in August 2008 to collect data systematically on funding agencies. 15 Therefore, the analyses of articles funded by the tobacco industry could only be carried out from this year onward. The conclusions about the funding activity of the tobacco industry must be assessed in this context. It must also be said that not all tobacco companies could necessarily be found by the applied search strings. That is also a limitation inherent in most bibliometric analyses. To minimize this incompleteness, we included general company name affixes like, eg, tobacco industry or company with the variations of notation in addition to the names of the bigger tobacco companies. Not all authors’ affiliations with the tobacco industry could be identified, as they are sometimes hidden or not declared, or the authors are affiliated with third parties with close ties to the industry. Authors’ conflicts of interest with the tobacco industry are not always declared in academic publications. 46 Such is true for funding activities, in particular, if funding occurred indirectly by third parties. This limitation led to a decrease in data. As the representativeness of the generated database is mandatory, a reduction in the number of entries is acceptable.

Conclusion

Tobacco companies have promoted their business interests through PR campaigns and lobbying in science and academia, including by damaging the reputation of science, conducting their “own” research, or providing specific financial support. Studies by tobacco industry-affiliated authors or sponsored by the tobacco industry are less likely to be published in health-related peer-reviewed journals but more in chemistry, toxicology, pharmacology, or agricultural sciences. The Chinese governmental CNTC is the most research-supporting tobacco company, followed by the other ‘Big Tobacco’ companies. Certainly, conflicts of interest occur time and again. The scientific community, researchers, academic institutions, journals, and health-related science, in particular, should be skeptical about tobacco industry-supported research. The best way to control corporate influence on science is possibly structural changes in funding science, eg, transparent and independent funding processes where payments from the industry are independently administered. 47 Education programs like, eg, the Education Against Tobacco (EAT) prevention program 48 are helpful and necessary to reduce smoking prevalence and to raise awareness of the influence of the tobacco industry on science, policy, and public perception.

Supplemental Material

Supplemental Material - Activity of the Tobacco Industry in Research and Scientific Literature

Supplemental Material for Activity of the Tobacco Industry in Research and Scientific Literature by Markus Braun, Doris Klingelhöfer, Dörthe Brüggmann and David A. Groneberg in Tobacco Use Insights.

Authors Contributions: Conceptualization: M.B., D.K., and D.A.G. Methodology: M.B., D.K., and D.A.G. Investigation: M.B. and D.K. Visualization: M.B. and D.K. Data interpretation: M.B., D.K., D.B., and D.A.G. Writing - original draft: M.B. and D.K. Writing - review and editing: M.B., D.K., D.B., and D.A.G. All authors read and approved the final manuscript.

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding: The author(s) received no financial support for the research, authorship, and/or publication of this article.

Supplemental Material: Supplemental material for this article is available online.

Data Availability Statement

Bibliometric data are owned by and were obtained from the Web of Science database. The authors are not allowed to share the data publicly or privately. Any researcher with access to the Web of Science database can obtain the data using the methods described in the paper.

References

  • 1.Ochsner A, DeBakey M. Primary pulmonary malignancy: treatment by total pneumonectomy; analysis of 79 collected cases and presentation of 7 personal cases. Surg Gynecol Obstet. 1939;68:435-451. [PMC free article] [PubMed] [Google Scholar]
  • 2.Wynder EL, Graham EA. Tobacco smoking as a possible etiologic factor in bronchiogenic carcinoma; a study of 684 proved cases. J Am Med Assoc. 1950;143(4):329-336. doi: 10.1001/jama.1950.02910390001001 [DOI] [PubMed] [Google Scholar]
  • 3.Doyle JT, Dawber TR, Kannel WB, Kinch SH, Kahn HA. The relationship of cigarette smoking to coronary heart disease; the second report of the combined experience of the albany, ny. And Framingham, mass. Studies. JAMA. 1964;190:886-890. [PubMed] [Google Scholar]
  • 4.U.S. Department of Health and Human Services . The Health Consequences of Smoking: 50 Years of Progress. A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2014. Printed with corrections, January 2014. [Google Scholar]
  • 5.Brandt AM. Inventing conflicts of interest: a history of tobacco industry tactics. Am J Public Health. 2012;102(1):63-71. doi: 10.2105/AJPH.2011.300292. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.UCSF. Library. Industry DocumentsHill and Knowlton, Inc. Report of Activities through July 31, 1954. Philip Morris Records; Master Settlement Agreement. Unknown, 2012. https://www.industrydocuments.ucsf.edu/docs/fsyh0111 (Accessed on 14 March 2024).
  • 7.UCSF. Industry Documents Library. Dakin E, Forwarding Memorandum 1953 Ness motley law firm documents. Unknown. 2009. https://www.industrydocuments.ucsf.edu/docs/ymby0042. Accessed on 14 March 2024. [Google Scholar]
  • 8.Hirschhorn N, Bialous SA, Shatenstein S. Philip Morris' new scientific initiative: an analysis. Tobac Control. 2001;10(3):247-252. doi: 10.1136/tc.10.3.247 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Cummings KM, Morley CP, Hyland A. Failed promises of the cigarette industry and its effect on consumer misperceptions about the health risks of smoking. Tobac Control. 2002;11(Suppl 1):I110-I117. doi: 10.1136/tc.11.suppl_1.i110 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Changeux J, Amoura Z, Rey F, Miyara M. A nicotinic hypothesis for Covid-19 with preventive and therapeutic implications. Qeios. 2020. https://www.qeios.com/read/FXGQSB.2. Accessed on 13 November 2023. [DOI] [PubMed] [Google Scholar]
  • 11.Miyara M, Tubach F, Pourcher V, et al. Low rate of daily active tobacco smoking in patients with symptomatic COVID-19. Qeios. 2020. https://www.qeios.com/read/WPP19W.4. Accessed on 13. November 2023. [Google Scholar]
  • 12.Horel S, Keyzer T. Covid 19: how harm reduction advocates and the tobacco industry capitalised on the pandemic to promote nicotine. BMJ. 2021;373:n1303. doi: 10.1136/bmj.n1303. [DOI] [PubMed] [Google Scholar]
  • 13.Groneberg-Kloft B, Fischer TC, Quarcoo D, Scutaru C. New quality and quantity indices in science (NewQIS): the study protocol of an international project. J Occup Med Toxicol. 2009;4:16. doi: 10.1186/1745-6673-4-16 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Kusma B, Scutaru C, Quarcoo D, Welte T, Fischer TC, Groneberg-Kloft B. Tobacco control: visualisation of research activity using density-equalizing mapping and scientometric benchmarking procedures. Int J Environ Res Publ Health. 2009;6(6):1856-1869. doi: 10.3390/ijerph6061856 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Liu WS, Tang L, Hu GY. Funding information in Web of Science: an updated overview. Scientometrics. 2020;122(3):1509-1524. doi: 10.1007/s11192-020-03362-3 [DOI] [Google Scholar]
  • 16.Chesley AL. Chemistry as an aid to the tobacco industry. J Ind Eng Chem. 1922;14:817-819. doi: 10.1021/ie50153a034 [DOI] [Google Scholar]
  • 17.Dowling F. Tobacco amblyopia - some recent examinations made to determine the influence of tobacco on vision among the employees of the tobacco factories of Cincinnati. J Am Med Assoc. 1900;34:462-464. [Google Scholar]
  • 18.OxySuisse . OXY. https://www.oxyromandie.org/. (Accessed on 09 February 2023).
  • 19.RTI . International. https://www.rti.org/. (Accessed on 09 February 2023).
  • 20.CCV . Cancer Council Victoria. https://www.cancervic.org.au/. Accessed on 09 February 2023.
  • 21.ADIC . Alcohol and drug information Centre. 2023. https://adicsrilanka.org/. Accessed on 09 February 2023.
  • 22.UKCTAS . UK Centre for tobacco and alcohol studies. https://www.ukctas.net/. (Accessed on 09 February 2023).
  • 23.ACS . Ameriscan cancer society. 2023. https://www.cancer.org/. Accessed on 09 02 2023.
  • 24.DNB . Deutsche Nationalbibliothek. https://d-nb.info/010409467. Accessed on 16 March 2023.
  • 25.Greenberg DS. Tobacco: after publicity surge, surgeon General's report seems to have little enduring effect. Science. 1964;145(3636):1021-1022. doi: 10.1126/science.145.3636.1021 [DOI] [PubMed] [Google Scholar]
  • 26.Schick S, Glantz S. Scientific analysis of second-hand smoke by the tobacco industry, 1929-1972. Nicotine Tob Res. 2005;7(4):591-612. doi: 10.1080/14622200500185082 [DOI] [PubMed] [Google Scholar]
  • 27.Hirschhorn N, Bialous SA. Second hand smoke and risk assessment: what was in it for the tobacco industry? Tobac Control. 2001;10(4):375-382. doi: 10.1136/tc.10.4.375 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Johnson WR, Hale RW, Clough SC. Letter: formation of molecular nitrogen by a burning cigarette. Nature. 1973;244(5410):51-52. doi: 10.1038/244051a0 [DOI] [PubMed] [Google Scholar]
  • 29.Johnson WR, Hale RW, Clough SC, Chen PH. Chemistry of the conversion of nitrate nitrogen to smoke products. Nature. 1973;243(5404):223-225. doi: 10.1038/243223a0 [DOI] [PubMed] [Google Scholar]
  • 30.McCormick A, Nicholson MJ, Baylis MA, Underwood JG. Nitrosamines in cigarette smoke condensate. Nature. 1973;244(5413):237-238. doi: 10.1038/244237a0 [DOI] [PubMed] [Google Scholar]
  • 31.Comber R, Grasso P. The effects of chemical irritants and tobacco smoke condensate on the chorioallantoic membrane of the fertile hen's egg. Chem Biol Interact. 1973;6(1):25-34. doi: 10.1016/0009-2797(73)90083-5 [DOI] [PubMed] [Google Scholar]
  • 32.Editorial . Tobacco money and medical research. Nat Med. 1999;5(2):125. doi: 10.1038/5472 [DOI] [PubMed] [Google Scholar]
  • 33.Schoffel N, Bruggmann D, Klingelhofer D, Bendels MHK, Groneberg DA. Ulcerative colitis: a critical approach to the global research output employing density-equalizing mapping and scientometric methods. J Clin Gastroenterol. 2021;55(3):e19-e26. doi: 10.1097/MCG.0000000000001351 [DOI] [PubMed] [Google Scholar]
  • 34.Klingelhofer D, Braun M, Seeger-Zybok RK, Quarcoo D, Bruggmann D, Groneberg DA. Global research on Fabry's disease: demands for a rare disease. Mol Genet Genomic Med. 2020;8(9):e1163. doi: 10.1002/mgg3.1163 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Gan Q, Glantz SA. Relationship between the Chinese tobacco industry and academic institutions in China. Tobac Control. 2011;20(1):12-19. doi: 10.1136/tc.2010.036079 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Fang J, Lee K, Sejpal N. The China National Tobacco Corporation: from domestic to global dragon? Global Publ Health. 2017;12(3):315-334. doi: 10.1080/17441692.2016.1241293 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Burki TK. Conflicts of interest in tobacco industry-funded research. Lancet Oncol. 2021;22(6):758. doi: 10.1016/S1470-2045(21)00281-3 [DOI] [PubMed] [Google Scholar]
  • 38.Capps B. Can a good tree bring forth evil fruit? The funding of medical research by industry. Br Med Bull. 2016;118(1):5-15. doi: 10.1093/bmb/ldw014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Garne D, Watson M, Chapman S, Byrne F. Environmental tobacco smoke research published in the journal Indoor and Built Environment and associations with the tobacco industry. Lancet. 2005. Feb 26-Mar 4;365(9461):804-809. doi: 10.1016/S0140-6736(05)17990-2 [DOI] [PubMed] [Google Scholar]
  • 40.Wertz MS, Kyriss T, Paranjape S, Glantz SA. The toxic effects of cigarette additives. Philip Morris' project mix reconsidered: an analysis of documents released through litigation. PLoS Med. 2011;8(12):e1001145. doi: 10.1371/journal.pmed.1001145 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.White J, Parascandola M, Bero L. Tobacco industry research and protection of human subjects: a case study of R. J. Reynolds. Nicotine Tob Res. 2007;9(11):1213-1225. doi: 10.1080/14622200701648425 [DOI] [PubMed] [Google Scholar]
  • 42.King J, Yamey G. Why journals should not publish articles funded by the tobacco industry. BMJ. 2000;321(7268):1074-1076. doi: 10.1136/bmj.321.7268.1074 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.McKee M, Allebeck P. Why the European Journal of Public Health will no longer publish tobacco industry-supported research. Eur J Publ Health. 2014;24(2):182. doi: 10.1093/eurpub/cku001 [DOI] [PubMed] [Google Scholar]
  • 44.Bero LA. Tobacco industry manipulation of research. Publ Health Rep. Mar-Apr 2005;120(2):200-208. doi: 10.1177/003335490512000215 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.van den Berg I, de Jeu M, Boytchev H. Tobacco funded research: how even journals with bans find it hard to stem the tide of publications. BMJ. 2024;385:q1153. doi: 10.1136/bmj.q1153 [DOI] [PubMed] [Google Scholar]
  • 46.McDonald A, McCausland K, Thomas L, Daube M, Jancey J. Smoke and mirrors? Conflict of interest declarations in tobacco and e-cigarette-related academic publications. Aust N Z J Publ Health. 2023;47(3):100055. doi: 10.1016/j.anzjph.2023.100055 [DOI] [PubMed] [Google Scholar]
  • 47.Cohen JE, Zeller M, Eissenberg T, et al. Criteria for evaluating tobacco control research funding programs and their application to models that include financial support from the tobacco industry. Tobac Control. 2009;18(3):228-234. doi: 10.1136/tc.2008.027623 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Brinker TJ, Stamm-Balderjahn S, Seeger W, Klingelhöfer D, Groneberg DA. Education against Tobacco (EAT): a quasi-experimental prospective evaluation of a multinational medical-student-delivered smoking prevention programme for secondary schools in Germany. BMJ Open. 2015;5(9):ARTNe008093. doi: 10.1136/bmjopen-2015-008093 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental Material - Activity of the Tobacco Industry in Research and Scientific Literature

Supplemental Material for Activity of the Tobacco Industry in Research and Scientific Literature by Markus Braun, Doris Klingelhöfer, Dörthe Brüggmann and David A. Groneberg in Tobacco Use Insights.

Data Availability Statement

Bibliometric data are owned by and were obtained from the Web of Science database. The authors are not allowed to share the data publicly or privately. Any researcher with access to the Web of Science database can obtain the data using the methods described in the paper.


Articles from Tobacco Use Insights are provided here courtesy of SAGE Publications

RESOURCES